Back to Search
Start Over
The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart.
- Source :
-
Cardiovascular research [Cardiovasc Res] 2002 Aug 15; Vol. 55 (3), pp. 681-9. - Publication Year :
- 2002
-
Abstract
- Objectives: Ischemic preconditioning (PC) reduces myocardial infarction by a mechanism that involves opening of mitochondrial ATP-dependent potassium channels (mK(ATP)), reactive oxygen species (ROS), and possibly activation of p38 mitogen-activated protein kinase (p38 MAPK). The actual order of these steps, however, is a matter of current debate. This study examined whether protection afforded by menadione, which protects by causing mitochondria to produce ROS, requires mK(ATP) opening. In addition, we tested whether protection from anisomycin, a p38 MAPK activator, is dependent on ROS production.<br />Methods and Results: Isolated, buffer-perfused rat hearts were pretreated with menadione, and infarction was assessed after 30 min of regional ischemia and 120 min of reperfusion. Menadione reduced infarction in a dose-dependent manner with an EC(50) of 270 nM. Menadione's infarct-limiting effect was insensitive to 200 microM 5-hydroxydecanoate (5HD), an mK(ATP) channel blocker, whereas protection by diazoxide and PC were blocked by 5HD. Anisomycin caused hearts to resist infarction and this protective effect was abrogated by SB203580, a p38 MAPK inhibitor, and 2-mercaptopropionylglycine (MPG), a free radical scavenger.<br />Conclusions: These results indicate that mK(ATP) opening occurs upstream of mitochondrial ROS generation in the protective pathway. Furthermore, protection afforded by anisomycin was p38 MAPK- and ROS-dependent.
- Subjects :
- Animals
Anisomycin pharmacology
Decanoic Acids pharmacology
Diazoxide pharmacology
Enzyme Activators pharmacology
Enzyme Inhibitors pharmacology
Free Radical Scavengers pharmacology
Free Radicals metabolism
Hydroxy Acids pharmacology
Imidazoles pharmacology
Male
Mitogen-Activated Protein Kinases antagonists & inhibitors
Mitogen-Activated Protein Kinases metabolism
Myocardial Infarction metabolism
Perfusion
Potassium Channel Blockers pharmacology
Pyridines pharmacology
Rats
Rats, Wistar
Tiopronin pharmacology
Vitamin K 3 pharmacology
p38 Mitogen-Activated Protein Kinases
Ischemic Preconditioning, Myocardial methods
Mitochondria, Heart metabolism
Myocardial Infarction prevention & control
Potassium Channels metabolism
Signal Transduction physiology
Subjects
Details
- Language :
- English
- ISSN :
- 0008-6363
- Volume :
- 55
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Cardiovascular research
- Publication Type :
- Academic Journal
- Accession number :
- 12160965
- Full Text :
- https://doi.org/10.1016/s0008-6363(02)00452-2